IBDoc Canadian User Performance Evaluation

IBDoc® Citation:

Alice C Moore, Vivian W Huang, Raymond Bourdages, Richard N Fedorak, Christian Reinhard, Yvette Leung, Brian Bressler, Greg Rosenfeld; IBDoc Canadian User Performance Evaluation, Inflammatory Bowel Diseases, , izy357, DOI: https://doi.org/10.1093/ibd/izy357 PMID: 30535387

Highlights from this Publication

  • “The majority of patients found it easy-to-use and felt that most patients would be able to learn how to use it quickly without the support of an assisting person.”
  • “Eighty-five percent of patients agreed to use the IBDoc in the future.”
  • “This study also showed a good correlation between the FC measurements from the IBDoc and the ELISA method, with no false positives or negatives…”
  • “This study further strengthens the evidence of accuracy of the IBDoc, a home-based FC monitoring kit, and demonstrates that this technology is acceptable to patients to use. It may therefore enable clinicians to more easily adopt a treat-to-target approach, improve long-term outcomes and patients’ quality of life with IBD…”

Health Canada License: 98903
US: Not available for Sale in the US.